BioLoomics

Boulder, CO · Founded 2019 · Privately Held (backing)

Developer of antibody-based therapeutics designed for enhanced drug delivery in oncology. BioLoomics is based in Boulder, CO and was founded in 2019. Its last reported valuation was $22.4 million in Mar 2023. It has raised $10.4 million across 4 recorded rounds; the latest was a $450,000 seed round in Aug 2025.

Last reported valuation
$22.4M
Oct 2026
Priced at
—
Total raised
$10.4M
Last round
Seed Round
Aug 2025

Who backs BioLoomics?

12 investors
InvestorType
Innovation EndeavorsVenture capital
Horizons VenturesVenture capital
Hummingbird VenturesOther
BoxOne VenturesOther
Ms2 CapitalFamily office
Boom Capital Ventures—
Colorado Venture Capital Authority—
Cooley—
GC&H Investments—
TechU Ventures—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BioLoomics investors

12 investors are on record for BioLoomics, including Innovation Endeavors, Horizons Ventures, Hummingbird Ventures and BoxOne Ventures. The seed round in Aug 2025 drew 5 investors.

Free account
More of BioLoomics with a free account
  • ·The complete investor list: 12 names
  • ·Watch BioLoomics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like BioLoomics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View